Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
This guide reviews criteria to determine the best cheap dividend ETF, including cost structure, track record, and diversification benefits for investors.
22,535 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Mortgage rates fall multiyear as bond markets stabilize and spreads tighten, signaling stronger spring demand for hom...
Bitcoin pushes toward 65K as inflation cools, and Pi Network’s PI shows a robust rebound, highlighting divergent move...
A weekend surge in airspace closures driven by regional tensions has forced widespread flight cancellations and route...
A one-time lottery windfall can trigger IRMAA surcharges, lifting Medicare premiums for the following year. Here's ho...
A solid move by a seasoned fund—Alpine Capital Research increases its Arrow Electronics position. Learn what this cou...
Lucid stock bounces back after a dramatic drop fueled by rumors. This guide explains what drove the move, what it mea...
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Point closes $508.6m securitization, the largest HEI-backed deal to date, as institutional buyers pile into home equi...
Toobit marks its third anniversary with a $3.5 million prize pool and a Porsche Taycan grand prize as it rolls out tr...
Small-cap stocks are delivering the sharpest outperformance versus the S&P 500 in years, with a roughly 20% YTD g...
Apple unveiled a refreshed iPhone and iPad Air lineup with bigger storage, underscoring a broader AI push. The move a...